Chul‐Soo Cho

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

Mark C. Genovese, Maria Greenwald, Chul‐Soo Cho et al. · Arthritis & Rheumatology · 2014 · 205 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts

Mi‐La Cho, Chul‐Soo Cho, So‐Youn Min et al. · Arthritis & Rheumatism · 2002 · 78 citations

Medicine, Clinical Sciences, Pathobiology +17

Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate

Jin‐Sun Kong, Seung‐Ah Yoo, Hyun Ah Kim et al. · Arthritis & Rheumatism · 2009 · 77 citations

Medicine, Immunology, Pharmacology +17

Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies

Ki‐Jo Kim, In‐Woon Baek, Chong‐Hyeon Yoon et al. · British Journal of Haematology · 2013 · 61 citations

Medicine, Hematology, Immunology +17

Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro‐inflammatory cytokines

Chang‐Ki Min, Seok Lee, Yoo‐Jin Kim et al. · European Journal Of Haematology · 2006 · 55 citations

Medicine, Immunology, Pharmacology +17